Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Prima Andalan Mandiri Tbk. (MCOL) Price & Performance

UBC Medical Indonesia Tbk.Trade
Prima Andalan Mandiri Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Prima Andalan Mandiri Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Prima Andalan Mandiri Tbk. trades at Rp3,780 (market cap 13.48T, 17.2K 24h volume). The key difference: Prima Andalan Mandiri Tbk. is far larger — about 23.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 17.2K). Which is the better fit depends on your goals.

LABSMCOL
Market Cap
576.7B13.48T
Volume
3.48M17.2K
Lot
34.82K172
Turnover
522.79M65.64M
Average Price
150.133,816.28
Value
522.79M65.64M
Indicative Equilibrium Price
1483,780
Indicative Equilibrium Volume
3502

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MCOL
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Prima Andalan Mandiri Tbk.

PT Prima Andalan Mandiri Tbk (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Nurul Hidajati Handoko, S.H., No. 1 dated June 1, 2005. The Company started commercial activities in 2011.

Read more on MCOL